Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease

Apostol, 2003, A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila, Proc Natl Acad Sci USA, 100, 5950, 10.1073/pnas.2628045100 Brand, 1993, Targeted gene expression as a means of altering cell fates and generating dominant phenotypes, Development, 118, 401, 10.1242/dev.118.2.401 Casas, 2004, Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model, Am J Pathol, 165, 1289, 10.1016/S0002-9440(10)63388-3 Crowther, 2002, Familial conformational diseases and dementias, Hum Mutat, 20, 1, 10.1002/humu.10100 Dahlgren, 2002, Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability, J Biol Chem, 277, 32046, 10.1074/jbc.M201750200 Davis, 2003, What can rodent models tell us about cognitive decline in Alzheimer’s disease?, Mol Neurobiol, 27, 249, 10.1385/MN:27:3:249 Dickson, 1997, The pathogenesis of senile plaques, J Neuropathol Exp Neurol, 56, 321, 10.1097/00005072-199704000-00001 Feany, 2000, A Drosophila model of Parkinson’s disease, Nature, 404, 394, 10.1038/35006074 Ganetzky, 1978, On the relationship between senescence and age related changes in two wild-type strains of Drosophila melanogaster, Exp Gerontol, 13, 189, 10.1016/0531-5565(78)90012-8 Glabe, 2001, Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease, J Mol Neurosci, 17, 137, 10.1385/JMN:17:2:137 Gouras, 2000, Intraneuronal Abeta42 accumulation in human brain, Am J Pathol, 156, 15, 10.1016/S0002-9440(10)64700-1 Green, 2000, The necrotic gene in Drosophila corresponds to one of a cluster of three Serpin transcripts mapping at 43A1.2, Genetics, 156, 1117, 10.1093/genetics/156.3.1117 Greeve, 2004, Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila, J Neurosci, 24, 3899, 10.1523/JNEUROSCI.0283-04.2004 Gyure, 2001, Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome, Arch Pathol Lab Med, 125, 489, 10.5858/2001-125-0489-IAAPDO Hardy, 2002, The amyloid hypothesis of Alzheimer’s disease, Science, 297, 353, 10.1126/science.1072994 Hirayama, 2003, Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome, Brain Dev, 25, 180, 10.1016/S0387-7604(02)00209-7 Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 Iijima, 2004, Dissecting the pathological effects of human A{beta}40 and A{beta}42 in Drosophila, Proc Natl Acad Sci USA, 101, 6623, 10.1073/pnas.0400895101 Iwatsubo, 1995, Amyloid beta protein (A beta) deposition, Ann Neurol, 37, 294, 10.1002/ana.410370305 Iwatsubo, 1994, Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals, Neuron, 13, 45, 10.1016/0896-6273(94)90458-8 Jarrett, 1993, Seeding ‘one-dimensional crystallization’ of amyloid, Cell, 73, 1055, 10.1016/0092-8674(93)90635-4 Kayed, 2003, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science, 300, 486, 10.1126/science.1079469 Klunk, 1989, Quantitative evaluation of Congo red binding to amyloid-like proteins with a β-pleated sheet conformation, J Histochem Cytochem, 37, 1273, 10.1177/37.8.2666510 Kumar-Singh, 2000, Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer’s disease, Hum Mol Genet, 9, 2589, 10.1093/hmg/9.18.2589 LaFerla, 1997, Neuronal cell death in Alzheimer’s disease correlates with apoE uptake and intracellular Abeta stabilization, J Clin Invest, 100, 310, 10.1172/JCI119536 Lai, 2003, Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities, J Biol Chem, 278, 22475, 10.1074/jbc.M300974200 Lambert, 1998, Diffusible, nonfibrillar ligands derived from Abeta 1–42 are potent central nervous system neurotoxins, Proc Natl Acad Sci USA, 95, 6448, 10.1073/pnas.95.11.6448 Lashuel, 2002, Neurodegenerative disease, Nature, 418, 291, 10.1038/418291a Lashuel, 2003, Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores, J Mol Biol, 332, 795, 10.1016/S0022-2836(03)00927-6 Le Bourg, 1992, Hypergravity and aging in Drosophila melanogaster: 4. Climbing activity, Gerontology, 38, 59, 10.1159/000213307 Lorenzo, 1994, β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red, Proc Natl Acad Sci USA, 91, 12243, 10.1073/pnas.91.25.12243 Mori, 2002, Intraneuronal Abeta42 accumulation in Down syndrome brain, Amyloid, 9, 88, 10.3109/13506120208995241 Murakami, 2002, Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1–42 mutants of familial Alzheimer’s disease at positions 21–23, Biochem Biophys Res Commun, 294, 5, 10.1016/S0006-291X(02)00430-8 Naslund, 2000, Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline, JAMA, 283, 1571, 10.1001/jama.283.12.1571 Nilsberth, 2001, The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation, Nat Neurosci, 4, 887, 10.1038/nn0901-887 Podlisny, 1998, Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by Congo Red, Biochemistry, 37, 3602, 10.1021/bi972029u Puchtler, 1965, Congo red as a stain for fluorescence microscopy of amyloid, J Histochem Cytochem, 13, 693, 10.1177/13.8.693 Puglielli, 2003, Alzheimer’s disease, Nat Neurosci, 6, 345, 10.1038/nn0403-345 Reisberg, 2003, Memantine in moderate-to-severe Alzheimer’s disease, N Engl J Med, 348, 1333, 10.1056/NEJMoa013128 Sánchez, 2003, Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders, Nature, 421, 373, 10.1038/nature01301 Selkoe, 2001, Alzheimer’s disease, Physiol Rev, 81, 741, 10.1152/physrev.2001.81.2.741 Ultsch, 1993, Glutamate receptors of Drosophila melanogaster, FEBS Lett, 324, 171, 10.1016/0014-5793(93)81387-F Walsh, 2002, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 416, 535, 10.1038/416535a Westerman, 2002, The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer’s disease, J Neurosci, 22, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 Wilcock, 1982, Plaques, tangles and dementia, J Neurol Sci, 56, 343, 10.1016/0022-510X(82)90155-1 Yang, 1999, Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1 –42, J Biol Chem, 274, 20650, 10.1074/jbc.274.29.20650 Zhang, 2002, Selective cytotoxicity of intracellular amyloid beta peptide 1–42 through p53 and Bax in cultured primary human neurons, J Cell Biol, 156, 519, 10.1083/jcb.200110119